多巣性運動ニューロパチー:疫学と治療の実態

  • 松井 尚子
    徳島大学大学院ヘルスバイオサイエンス研究部臨床神経科学

書誌事項

タイトル別名
  • Multifocal motor neuropathy: Current review of epidemiology and treatment

説明

The diagnosis of multifocal motor neuropathy (MMN) is often missed because MMN disguises itself as a motor neuron disease and is considered relatively rare. Detailed epidemiological studies of MMN have not been undertaken. We therefore conducted a nationwide survey of MMN in comparison with amyotrophic lateral sclerosis (ALS). This retrospective study examined 47 patients with MMN and 1,051 patients with ALS from major neuromuscular centers in Japan from 2005 to 2009. MMN had a younger age of onset and was more common in males than ALS. The ratio of MMN to ALS patients (0-0.10) varied among the centers, but mostly converged to 0.05. The prevalence was estimated to be 0.3 cases for MMN and 6.63 cases for ALS per 100,000 persons. Twenty-five MMN patients (54.2%) showed conduction block. Thirty-four (75%) of 45 MMN patients received intravenous immunoglobulin exhibited a favorable outcome. It is expected that more sensitive indicators of conduction block or focal demyelinating lesions than currently available MMN diagnostic criteria would further increase the ratio of MMN to ALS patients and the total number of MMN patients who can benefit from treatment. MMN is by no means a rare disorder but should be accurately diagnosed in all neuromuscular centers.<br>

収録刊行物

  • 臨床神経学

    臨床神経学 52 (11), 920-922, 2012

    日本神経学会

被引用文献 (1)*注記

もっと見る

参考文献 (9)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

  • CRID
    1390001205036619008
  • NII論文ID
    130004505210
  • DOI
    10.5692/clinicalneurol.52.920
  • COI
    1:STN:280:DC%2BC3s7ns1yitQ%3D%3D
  • ISSN
    18820654
    0009918X
  • PubMed
    23196468
  • 本文言語コード
    ja
  • データソース種別
    • JaLC
    • Crossref
    • PubMed
    • CiNii Articles
    • KAKEN
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ